Lv3
208 积分 2024-10-28 加入
Liquid Biopsies for Cancer
7天前
已完结
Is There Still Room for Monotherapy in EGFR -Mutated Non–Small Cell Lung Cancer?
7天前
已关闭
Osimertinib With or Without Chemotherapy in Advanced Non–Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations A Randomized Clinical Trial
8天前
已关闭
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
13天前
已完结
Chinese expert consensus on radiotherapy combined with immunotherapy for unresectable lung cancer (2026 Edition)
1个月前
已完结
New biomarkers for antibody-drug conjugates in lung cancer the pathologist’s perspective
1个月前
已完结
Durable Gains and Persistent Questions From the ASTRUM-005 Trial
2个月前
已完结
Capmatinib plus nazartinib in patients with EGFR-mutated non–small cell lung cancer
3个月前
已完结
Targeted precision Strike in Extensive-Stage small cell lung Cancer: Current advances and future Perspectives for Antibody–Drug conjugates
5个月前
已关闭
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial
7个月前
已完结
皖公网安备34019202002308
